DRTSAlpha Tau Medical
About Alpha Tau Medical
Alpha Tau Medical (NASDAQ:DRTS) specializes in developing cancer treatments based on its pioneering Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) technology. This advanced technology targets solid tumors with high precision, offering a new hope in the fight against cancer. Currently engaged in various stages of clinical trials across multiple cancer types, the company aims to transform cancer treatment paradigms by providing highly effective, localized therapy with minimal side effects. With an objective to broaden the horizon of cancer care, Alpha Tau Medical is committed to advancing its research and expanding the application of its technology to benefit patients worldwide.
What is DRTS known for?
Snapshot
Public US
Ownership
2015
Year founded
121
Employees
Tel Aviv, Israel
Head office
1 of 5
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...
Operations
All Locations
State of Israel
Produtos e/ou serviços de Alpha Tau Medical
- Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) - A breakthrough technology for treating solid tumors by delivering high-precision alpha radiation directly to the cancerous site.
- R&D Services - Provides research and development services in the field of alpha radiation therapy, including preclinical studies and clinical trial design.
- Consulting Services - Offers expert consulting in radiopharmaceuticals, providing insights and strategies for developing and commercializing alpha radiation therapies.
- Training Programs - Develops and delivers training programs for healthcare professionals on the safe and effective use of alpha radiation therapy in treating cancer.
- Partnership Programs - Engages in strategic partnerships to advance the development and application of alpha radiation therapy in oncology.
- Technology Licensing - Licenses its proprietary alpha radiation therapy technology to other companies for development and commercialization in specific territories.
equipe executiva do Alpha Tau Medical
- Mr. Uzi SoferCEO & Chairman
- Mr. Raphi LevyChief Financial Officer
- Mr. Amnon GatChief Operations Officer
- Mr. Ronen SegalChief Technology Officer
- Dr. Robert B. Den M.D.Chief Medical Officer & Member of Scientific Advisory Board
- Prof. Yona KeisariChief Scientific Officer & Member of Scientific Advisory board
- Ms. Rebecca BeckerVice President of legal
- Mr. Peter M. MelnykChief Commercial Officer
- Prof. Itzhak KelsonChief Physics Officer & Member of Scientific Advisory Board
- Ms. Yael ZeigerCorporate Controller